VOROLANIB

Clinical trials for VOROLANIB explained in plain language.

Never miss a new study

Get alerted when new VOROLANIB trials appear

Sign up with your email to follow new studies for VOROLANIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo may help save kidneys in High-Risk cancer patients

Disease control Recruiting now

This study tests whether giving two drugs (pucotenlimab and vorolanib) before surgery can shrink kidney tumors enough to allow partial kidney removal instead of full removal. It includes 21 adults with high-risk clear cell renal cancer who need surgery but have tumors that make k…

Matched conditions: VOROLANIB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 12, 2026 12:07 UTC

VOROLANIB

Get alerted when new VOROLANIB trials appear

New drug combo may help save kidneys in High-Risk cancer patients